Advanced Malignancies Clinical Trials

A listing of Advanced Malignancies medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 822 clinical trials
None
Clinical Study of JS201 in Patients With Advanced Malignant Tumors

in the patients with advanced malignant tumors who have progression after or on the standard of care, or no effective standard therapeutic regimen. This study is divided into three periods: dose

  • 0 views
  • 15 Aug, 2021
  • 1 location
None
Study of IBI323 in Patients With Advanced Malignancies

The purpose of this study is to evaluate safety, tolerability and efficacy of IBI323(anti-LAG-3/PD-L1) or in combination with chemotherapy in participants with advanced malignancies. Another

  • 0 views
  • 18 Sep, 2021
  • 1 location
None
Study of E7386 in Subjects With Selected Advanced Neoplasms

This study will be conducted to assess the safety/tolerability profile of E7386 as a single agent administered orally in participants with selected advanced or recurrent neoplasms and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of E7386.

  • 54 views
  • 26 Jan, 2021
  • 3 locations
None
Study of IBI318 in Participants With Advanced Malignancies

This study is an open, multicenter, Ia/Ib phase study to evaluate the safety, tolerability, and initial efficacy of IBI318 in the treatment of patients with advanced malignancy.

  • 7 views
  • 23 Jan, 2021
  • 1 location
None
Study of CPI-100 in Patients With Advanced Tumors

This is a prospective, open-label, 2-arm, non-randomized study of CPI-100 in patients with advanced tumors. CPI-100 is administered via intravenous infusion in a 3 + 3 study design to identify

  • 5 views
  • 15 Aug, 2021
  • 3 locations
None
A Study of SHR-1501 in Patients With Advanced Tumors

The purpose of this study is to evaluate the safety and tolerability of SHR-1501 in patients with advanced malignancies .

  • 0 views
  • 24 Jan, 2021
  • 1 location
None
A Study of TQB3455 Tablets in Subjects With Advanced Malignancies

This is a open-label, multicenter, phase I study to evaluate tolerance and pharmacokinetics of TQB3455 tablets in subjects with advanced malignancies.

measurable disease
idh2 gene mutation
  • 0 views
  • 24 Jan, 2021
  • 1 location
None
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

The study is investigating efficacy, safety and tolerability of DNA-damage Response Agents (or Combinations), in participants with advanced/metastatic solid malignancies whose tumours contain molecular alterations

  • 0 views
  • 12 Sep, 2021
  • 23 locations
None
BI-1808 as a Single Agent and With Pembrolizumab in Treatment of Advanced Malignancies

advanced malignancies, whose disease has progressed after standard therapy. For the purpose of this study, subjects with advanced malignancies includes subjects with advanced solid tumors (where

  • 4 views
  • 21 Aug, 2021
  • 8 locations
None
  • 0 views
  • 16 Feb, 2021
  • 1 location